Skip to main content
NPJ Genomic Medicine logoLink to NPJ Genomic Medicine
. 2019 Jul 1;4:16. doi: 10.1038/s41525-019-0090-y

Author Correction: A framework to identify contributing genes in patients with Phelan-McDermid syndrome

Anne-Claude Tabet 1,2,3,4,#, Thomas Rolland 2,3,4,#, Marie Ducloy 2,3,4, Jonathan Lévy 1, Julien Buratti 2,3,4, Alexandre Mathieu 2,3,4, Damien Haye 1, Laurence Perrin 1, Céline Dupont 1, Sandrine Passemard 1, Yline Capri 1, Alain Verloes 1, Séverine Drunat 1, Boris Keren 5, Cyril Mignot 6, Isabelle Marey 7, Aurélia Jacquette 7, Sandra Whalen 7, Eva Pipiras 8, Brigitte Benzacken 8, Sandra Chantot-Bastaraud 9, Alexandra Afenjar 10, Delphine Héron 10, Cédric Le Caignec 11, Claire Beneteau 11, Olivier Pichon 11, Bertrand Isidor 11, Albert David 11, Laila El Khattabi 12, Stephan Kemeny 13, Laetitia Gouas 13, Philippe Vago 13, Anne-Laure Mosca-Boidron 14, Laurence Faivre 15, Chantal Missirian 16, Nicole Philip 16, Damien Sanlaville 17, Patrick Edery 18, Véronique Satre 19, Charles Coutton 19, Françoise Devillard 19, Klaus Dieterich 20, Marie-Laure Vuillaume 21, Caroline Rooryck 21, Didier Lacombe 21, Lucile Pinson 22, Vincent Gatinois 22, Jacques Puechberty 22, Jean Chiesa 23, James Lespinasse 24, Christèle Dubourg 25, Chloé Quelin 25, Mélanie Fradin 25, Hubert Journel 26, Annick Toutain 27, Dominique Martin 28, Abdelamdjid Benmansour 1, Claire S Leblond 2,3,4, Roberto Toro 2,3,4, Frédérique Amsellem 29, Richard Delorme 2,3,4,29, Thomas Bourgeron 2,3,4,
PMCID: PMC6602945  PMID: 31285849

Correction to: npj Genomic Medicine 10.1038/s41525-017-0035-2, published online 23 October 2017

In the original published version of the Article, the ‘Population’ section included the statement that “the local Institutional Review Boards (IRB) at each clinical center approved the study. The methods were performed in accordance with relevant guidelines and regulations and approved by the Institut Pasteur IRB”. However, IRB approval was not granted because it was not necessary for this study. French regulations do not require IRB approval for studies which involve the reutilization of data provided that subjects provide written informed consent and retain the right to oppose the use of data at any time. All patients provided written informed consent for this study.

The statement was therefore updated to “Institutional Review Board approval was not required for this study. The methods were performed in accordance with relevant guidelines and regulations. For each patient, a parent or legal guardian provided written informed consent and retained the right to oppose the use of the data at any time” in the PDF and HTML versions of the Article.


Articles from NPJ Genomic Medicine are provided here courtesy of Nature Publishing Group

RESOURCES